How much does ruxolitinib cream (Opzelura) currently cost?

Ruxolitinib cream (trade name: Opzelura, also known as ruxolitinib ointment in Chinese) is a topical JAK inhibitor, mainly used to treat skin diseases such as non-segmental vitiligo and mild to moderate atopic dermatitis. The drug has not yet been approved for marketing in mainland China, so patients cannot purchase it directly in domestic hospitals or pharmacies for the time being and can only obtain it through overseas channels. For patients in need of treatment, this presents certain challenges in terms of drug purchase and cost.

In foreign markets, ruxolitinib cream is developed and produced by Incyte Company. As an original drug, its price is relatively expensive. According to different countries and drug specifications, the price of the original version of ruxolitinib cream is usually around more than 10,000 yuan, which is a high-cost drug. This is a considerable financial burden for patients who require long-term, daily external use, and has prompted many people to start looking for more affordable alternatives.

In comparison, countries such as Bangladesh have launched generic versions of ruxolitinib cream, which are more affordable, with each tube usually selling for only a few hundred yuan. The ingredients of generic drugs are basically the same as those of the original drugs, and their efficacy is similar. They are an alternative chosen by many patients under limited economic conditions. It should be noted that although generic drugs have obvious advantages in price, it is recommended to purchase them through regular overseas pharmacies or medical service platforms to ensure that the sources of drugs are legal and the quality is reliable.

In general, because ruxolitinib cream has not yet been launched in mainland China, patients can currently only obtain the drug through overseas drug purchase. Original drugs are more expensive, while generic drugs are more affordable and have certain economic advantages. When making a choice, patients should reasonably evaluate the most appropriate medication plan based on their own economic status, severity of the disease, and the doctor's medication recommendations, and ensure that the drug purchase channels are formal and safe to ensure medication effectiveness and health and safety.

Reference materials:https://www.opzelura.com/